@article{4426026a70f7402c987b4f35f1608b65,
title = "Obsessive-compulsive disorder during the COVID-19 pandemic",
author = "{Van Ameringen}, M. and B. Patterson and J. Turna and G. Lethbridge and {Goldman Bergmann}, C. and N. Lamberti and M. Rahat and B. Sideris and Francisco, {A. P.} and N. Fineberg and S. Pallanti and G. Grassi and M. Vismara and U. Albert and {Gedanke Shavitt}, R. and E. Hollander and J. Feusner and Rodriguez, {C. I.} and P. Morgado and B. Dell'Osso",
note = "Funding Information: Prof. Pallanti reports grant funding from NIH R21; consulting fees from Recordati, Angelini Pharma, GW Research Limited, Octapharma, SAGE Therapeutics INC, Biohaven Pharmaceuticals Inc and Gideon Ritcher PLC, all outside of the submitted work. Funding Information: Prof. Fineberg reports research funding from the National Institute for Health Research and COST Action; royalties from Oxford University Press; support for attending meetings/travel from the European college of Neuropsychopharmacology COST Action, International Forum of Mod and Anxiety disorders, British Association for Psychopharmacology, Royal College of Psychiatrists and the World Psychiatric Association; leadership roles at the International College of Obsessive Compulsive Spectrum Disorders (unpaid), MHRA and Orchard; she also leads an NHS treatment service for OCD, focusing on psychopharmacology and publishes on OCD treatments including psychopharmacology, all outside of the submitted work. Funding Information: Prof. Morgado reports receiving grants from FLAD, FCT and Funda{\c c}{\~a}o Calouste Gulbenkian; consulting fees from Janseen, Angelini, Lundbeck and Bial; honoraria from Astra Zeneca and Biogen as well as membership on the Board of Directors of Psychiatry of the Portuguese Medical Association, all outside of the submitted work. Funding Information: Dr. Gedanke Shavitt reports grant funding from the National Council for Scientific and Technological Development; honoraria from Lundbeck; and travel support from Lundbeck and Libbs all outside of the submitted work. Funding Information: Dr. Rodriguez has received research grant support from Biohaven Pharmaceuticals; has served as a consultant for Epiodyne and Biohaven Pharmaceuticals; and receives a stipend from APA Publishing for her role as Deputy Editor at The American Journal of Psychiatry, all outside of the submitted work. ",
year = "2022",
month = may,
doi = "10.1016/j.jpsychires.2022.02.001",
language = "English (US)",
volume = "149",
pages = "114--123",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
}
